# South Plains Financial, Inc.: financial statements, quarterly

SPFI · Nasdaq · CIK 1163668 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/spfi.md) · [Financials](/companies/spfi/financials.md) · [Filings](/companies/spfi/filings.md) · [Insiders](/companies/spfi/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/spfi/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Interest expense | $m | [20.8](/filings/0001140361-23-051927.md) | [22.1 d](/filings/0001140361-24-013519.md) | [23.4](/filings/0001140361-24-024557.md) | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Income tax | $m | [3.7](/filings/0001140361-24-045412.md) | [2.8 d](/filings/0001140361-26-008087.md) | [3.1](/filings/0001140361-25-017542.md) | [3.1](/filings/0001140361-25-028837.md) | [3.1](/filings/0001140361-25-040668.md) | [4.2 d](/filings/0001140361-26-008087.md) | [3.4](/filings/0001140361-26-019131.md) | [4.0](/filings/0001140361-26-031701.md) | [4.3](/filings/0001140361-25-040668.md) | [3.8 d](/filings/0001140361-26-008087.md) | [3.8](/filings/0001140361-26-019131.md) | [5.3](/filings/0001140361-26-031701.md) |
| Net income | $m | [13.5](/filings/0001140361-24-045412.md) | [10.3 d](/filings/0001140361-26-008087.md) | [10.9](/filings/0001140361-25-017542.md) | [11.1](/filings/0001140361-25-028837.md) | [11.2](/filings/0001140361-25-040668.md) | [16.5 d](/filings/0001140361-26-008087.md) | [12.3](/filings/0001140361-26-019131.md) | [14.6](/filings/0001140361-26-031701.md) | [16.3](/filings/0001140361-25-040668.md) | [15.3 d](/filings/0001140361-26-008087.md) | [14.5](/filings/0001140361-26-019131.md) | [19.0](/filings/0001140361-26-031701.md) |
| Diluted EPS | $ per share | [0.78](/filings/0001140361-24-045412.md) | not reported | [0.64](/filings/0001140361-25-017542.md) | [0.66](/filings/0001140361-25-028837.md) | [0.66](/filings/0001140361-25-040668.md) | not reported | [0.72](/filings/0001140361-26-019131.md) | [0.86](/filings/0001140361-26-031701.md) | [0.96](/filings/0001140361-25-040668.md) | not reported | [0.85](/filings/0001140361-26-019131.md) | [0.96](/filings/0001140361-26-031701.md) |
| Basic EPS | $ per share | [0.80](/filings/0001140361-24-045412.md) | not reported | [0.66](/filings/0001140361-25-017542.md) | [0.68](/filings/0001140361-25-028837.md) | [0.68](/filings/0001140361-25-040668.md) | not reported | [0.75](/filings/0001140361-26-019131.md) | [0.90](/filings/0001140361-26-031701.md) | [1.00](/filings/0001140361-25-040668.md) | not reported | [0.89](/filings/0001140361-26-019131.md) | [0.99](/filings/0001140361-26-031701.md) |

- Interest expense: us-gaap:InterestExpense
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [352](/filings/0001140361-23-051927.md) | [330](/filings/0001140361-25-007609.md) | [372](/filings/0001140361-24-024557.md) | [298](/filings/0001140361-24-035948.md) | [471](/filings/0001140361-24-045412.md) | [359](/filings/0001140361-26-008087.md) | [536](/filings/0001140361-25-017542.md) | [470](/filings/0001140361-25-028837.md) | [635](/filings/0001140361-25-040668.md) | [552](/filings/0001140361-26-031701.md) | [722](/filings/0001140361-26-019131.md) | [788](/filings/0001140361-26-031701.md) |
| Total assets | $m | [4,186](/filings/0001140361-23-051927.md) | [4,205](/filings/0001140361-25-007609.md) | [4,219](/filings/0001140361-24-024557.md) | [4,221](/filings/0001140361-24-035948.md) | [4,338](/filings/0001140361-24-045412.md) | [4,232](/filings/0001140361-26-008087.md) | [4,405](/filings/0001140361-25-017542.md) | [4,364](/filings/0001140361-25-028837.md) | [4,479](/filings/0001140361-25-040668.md) | [4,481](/filings/0001140361-26-031701.md) | [4,646](/filings/0001140361-26-019131.md) | [5,391](/filings/0001140361-26-031701.md) |
| Total liabilities | $m | [3,815](/filings/0001140361-23-051927.md) | [3,798](/filings/0001140361-25-007609.md) | [3,810](/filings/0001140361-24-024557.md) | [3,803](/filings/0001140361-24-035948.md) | [3,895](/filings/0001140361-24-045412.md) | [3,793](/filings/0001140361-26-008087.md) | [3,961](/filings/0001140361-25-017542.md) | [3,910](/filings/0001140361-25-028837.md) | [4,002](/filings/0001140361-25-040668.md) | [3,987](/filings/0001140361-26-031701.md) | [4,141](/filings/0001140361-26-019131.md) | [4,761](/filings/0001140361-26-031701.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | [0.0](/filings/0001140361-25-028837.md) | not reported | [1.4](/filings/0001140361-25-028837.md) | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [372](/filings/0001140361-24-045412.md) | [407](/filings/0001140361-26-008087.md) | [409](/filings/0001140361-25-028837.md) | [418](/filings/0001140361-25-040668.md) | [443](/filings/0001140361-25-040668.md) | [439](/filings/0001140361-26-031701.md) | [444](/filings/0001140361-26-031701.md) | [454](/filings/0001140361-26-031701.md) | [478](/filings/0001140361-25-040668.md) | [494](/filings/0001140361-26-031701.md) | [505](/filings/0001140361-26-031701.md) | [630](/filings/0001140361-26-031701.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [26.3 d](/filings/0001140361-24-045412.md) | [6.6 d](/filings/0001140361-26-008087.md) | [19.2](/filings/0001140361-25-017542.md) | [18.2 d](/filings/0001140361-25-028837.md) | [17.9 d](/filings/0001140361-25-040668.md) | [4.2 d](/filings/0001140361-26-008087.md) | [26.1](/filings/0001140361-26-019131.md) | [14.7 d](/filings/0001140361-26-031701.md) | [24.2 d](/filings/0001140361-25-040668.md) | [12.4 d](/filings/0001140361-26-008087.md) | [16.2](/filings/0001140361-26-019131.md) | [27.9 d](/filings/0001140361-26-031701.md) |
| Capital expenditure | $m | [1.2 d](/filings/0001140361-24-045412.md) | [(0.0) d](/filings/0001140361-26-008087.md) | [0.5](/filings/0001140361-25-017542.md) | [1.1 d](/filings/0001140361-25-028837.md) | [0.8 d](/filings/0001140361-25-040668.md) | [1.0 d](/filings/0001140361-26-008087.md) | [1.1](/filings/0001140361-26-019131.md) | [1.7 d](/filings/0001140361-26-031701.md) | [1.8 d](/filings/0001140361-25-040668.md) | [1.0 d](/filings/0001140361-26-008087.md) | [1.4](/filings/0001140361-26-019131.md) | [1.0 d](/filings/0001140361-26-031701.md) |
| Dividends paid | $m | [2.2 d](/filings/0001140361-24-045412.md) | [2.1 d](/filings/0001140361-26-008087.md) | [2.1](/filings/0001140361-25-017542.md) | [2.3 d](/filings/0001140361-25-028837.md) | [2.3 d](/filings/0001140361-25-040668.md) | [2.5 d](/filings/0001140361-26-008087.md) | [2.5](/filings/0001140361-26-019131.md) | [2.4 d](/filings/0001140361-26-031701.md) | [2.6 d](/filings/0001140361-25-040668.md) | [2.6 d](/filings/0001140361-26-008087.md) | [2.8](/filings/0001140361-26-019131.md) | [3.3 d](/filings/0001140361-26-031701.md) |
| Share repurchases | $m | [9.3 d](/filings/0001140361-24-045412.md) | [5.9 d](/filings/0001140361-26-008087.md) | [0.0](/filings/0001140361-25-017542.md) | [0.3 d](/filings/0001140361-25-028837.md) | [1.0 d](/filings/0001140361-25-040668.md) | [0.0 d](/filings/0001140361-26-008087.md) | [8.3](/filings/0001140361-26-019131.md) | [0.3 d](/filings/0001140361-26-031701.md) | [0.0 d](/filings/0001140361-25-040668.md) | [0.0 d](/filings/0001140361-26-008087.md) | [0.0](/filings/0001140361-26-019131.md) | [12.8 d](/filings/0001140361-26-031701.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividendsCommonStock
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [17.9](/filings/0001140361-23-051927.md) | [17.6](/filings/0001140361-24-024557.md) | [17.4](/filings/0001140361-24-035948.md) | [17.4](/filings/0001140361-24-045412.md) | [16.9](/filings/0001140361-25-017542.md) | [16.9](/filings/0001140361-25-028837.md) | [17.1](/filings/0001140361-25-040668.md) | [17.1](/filings/0001140361-26-019131.md) | [16.9](/filings/0001140361-26-031701.md) | [17.0](/filings/0001140361-25-040668.md) | [17.0](/filings/0001140361-26-019131.md) | [19.8](/filings/0001140361-26-031701.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 18,839,105 at 2026-08-04, from the cover of the [10-Q filed 2026-08-06](/filings/0001140361-26-031701.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.